MEI Pharma, Inc. (MEIP) is a publicly traded company in the Unknown sector. Across all available filings, 29 corporate insiders have executed 95 transactions totaling $28.4M, demonstrating a bearish sentiment with -$23.2M in net insider flow. The most recent transaction on May 17, 2024 involved a transaction of 3,100 shares valued at $9.8K.
No significant insider buying has been recorded for MEIP in the recent period.
No significant insider selling has been recorded for MEIP in the recent period.
Based on recent SEC filings, insider sentiment for MEIP is bearish with an Insider Alignment Score of 9/100 and a net flow of -$23.2M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at MEI Pharma, Inc. (MEIP) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 29 insiders are actively trading MEIP stock, having executed 95 transactions in the past 90 days. The most active insider is Jeani Delagardelle (Executive), who has made 2 transactions totaling $6.2M.
Get notified when executives and directors at MEIP file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| May 17, 2024 | D. Wood Steven | Executive | Award | 3,100 | $3.17 | $9.8K | |
| May 16, 2024 | P. Flynn James | Executive | Award | 7,900 | $3.16 | $25.0K | |
| Oct 20, 2023 | Kassam Moez | Executive | Exercise | 143,200 | $7.00 | $1.0M | Large |
| Oct 20, 2023 | Kassam Moez | Executive | Exercise | 35,800 | $7.00 | $250.6K | |
| Oct 20, 2023 | Lp Funicular Funds, | Executive | Exercise | 120,600 | $7.00 | $844.2K | Large |
| Oct 11, 2023 | Management Lp Anson Funds | Executive | Exercise | 10,000 | $7.00 | $70.0K | |
| Oct 11, 2023 | Management Lp Anson Funds | Executive | Exercise | 40,000 | $7.00 | $280.0K | |
| Oct 11, 2023 | Ma-weaver Jacob | Executive | Exercise | 30,000 | $7.00 | $210.0K | |
| Sep 22, 2023 | Ma-weaver Jacob | Executive | Purchase | 32,040 | $6.85 | $219.5K | |
| Sep 22, 2023 | Ross Winson Bruce | Executive | Purchase | 48,060 | $6.85 | $329.2K | |
| Sep 21, 2023 | Ma-weaver Jacob | Executive | Purchase | 22,400 | $6.46 | $144.7K | |
| Sep 21, 2023 | Kassam Moez | Executive | Purchase | 33,600 | $6.46 | $217.1K | |
| Sep 20, 2023 | Ma-weaver Jacob | Executive | Purchase | 80,000 | $6.01 | $480.8K | |
| Sep 20, 2023 | Kassam Moez | Executive | Purchase | 120,000 | $6.01 | $721.2K | Large |
| Feb 28, 2023 | Baltic Charles V III | Executive | Purchase | 81,500 | $0.23 | $18.7K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 35 | $25.8M | 76.7% |
Exercise (Options)(X) | 7 | $2.7M | 7.9% |
Purchase(P) | 33 | $2.6M | 7.7% |
Other(O) | 2 | $1.5M | 4.5% |
Payment(F) | 8 | $992.6K | 2.9% |
Exercise(M) | 3 | $62.8K | 0.2% |
Award(A) | 4 | $34.8K | 0.1% |
Other(J) | 2 | $0 | 0.0% |
Conversion(C) | 1 | $0 | 0.0% |
Insider selling pressure at MEI Pharma, Inc. has increased, with 29 insiders executing 95 transactions across all time. Total sales of $25.8M significantly outpace purchases of $2.6M, resulting in a net outflow of $23.2M. This selling activity appears largely discretionary, which may warrant closer attention from investors.